CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Submit a Drug for CDR Review

CADTH Collaborative Workspaces

All materials must adhere to the content, format, and organization specified in the Procedure and Submission Guidelines for the CADTH Common Drug Review and all applicable CADTH Pharmaceutical Review Updates.

To submit and contribute drug review information you must be registered with the CADTH Collaborative Workspaces. If you are a sponsor or designated consultant who intends to file a CDR application you may register by submitting completing the Registration Form.

If you have already registered, you may log in.


Before submitting to the CADTH, sponsors or designated consultants must be registered with CDR. This will provide access to a secure submit and contribute page and enable the electronic delivery of documents to CADTH.